HCPCS Code J9059

Injection, bendamustine hydrochloride (baxter), 1 mg
Code effective Jan 01, 2025

HCPCS Section
Drugs administered other than oral method, chemotherapy drugs

J9059 is a valid 2026 HCPCS code meaning Injection, bendamustine hydrochloride (baxter), 1 mg or (Inj bendamustine, baxter 1mg) for short. HCPCS J9059 has been effective since 01/01/2025 and applies to Medical care.


HCPCS Code Details - J9059

HCPCS Level II Code
Section J - Drugs administered other than oral method, chemotherapy drugs
HCPCS Code J9059
Description

Long description:
Injection, bendamustine hydrochloride (baxter), 1 mg

Short description:
Inj bendamustine, baxter 1mg

HCPCS Pricing indicator 51 - Drugs
Multiple pricing indicator A - Not applicable as HCPCS priced under one methodology
Coverage code C - Carrier judgment
BETOS2 code O1D - Chemotherapy
HCPCS Action code N - No maintenance for this code
Type of service 1 - Medical care
Effective date Effective Jan 01, 2025
Date added Added Jul 01, 2023
Termination date Dec 31, 2024

See also

  • HCPCS J9033 · Injection, bendamustine hydrochloride, 1 mg

  • HCPCS J9036 · Injection, bendamustine hydrochloride, (belrapzo/bendamustine), 1 mg

  • HCPCS J9056 · Injection, bendamustine hydrochloride (vivimusta), 1 mg

  • HCPCS J9058 · Injection, bendamustine hydrochloride (apotex), 1 mg

  • HCPCS J9060 · Injection, cisplatin, powder or solution, 10 mg

1 Two-digit numeric codes are Level I code modifiers copyrighted© by the American Medical Association's Current Procedural Terminology (CPT).

2 BETOS stands for “Berenson-Eggers Type Of Service”


HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, the Health Insurance Association of America, and the Blue Cross and Blue Shield Association). — Updated 6/23/2026

CPT® is a registered trademark of the American Medical Association (AMA). All rights reserved.